AAAAAA

   
Results: 1-24 |
Results: 24
VALUE OF LABORATORY INVESTIGATIONS IN CLINICAL SUSPICION OF CYTOMEGALOVIRUS-INDUCED UPPER GASTROINTESTINAL-TRACT ULCERATIONS IN HIV-INFECTED PATIENTS
Authors: DORIGOZETSMA JW VANDERMEER JTM TERSMETTE M TENKATE FJW DILLEN PWEW VANDERNOORDAA J
Citation: Jw. Dorigozetsma et al., VALUE OF LABORATORY INVESTIGATIONS IN CLINICAL SUSPICION OF CYTOMEGALOVIRUS-INDUCED UPPER GASTROINTESTINAL-TRACT ULCERATIONS IN HIV-INFECTED PATIENTS, Journal of medical virology, 49(1), 1996, pp. 29-33
RELATION BETWEEN CHANGES IN CELLULAR LOAD, EVOLUTION OF VIRAL PHENOTYPE, AND THE CLONAL COMPOSITION OF VIRUS POPULATIONS IN THE COURSE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: KOOT M VANTWOUT AB KOOTSTRA NA DEGOEDE REY TERSMETTE M SCHUITEMAKER H
Citation: M. Koot et al., RELATION BETWEEN CHANGES IN CELLULAR LOAD, EVOLUTION OF VIRAL PHENOTYPE, AND THE CLONAL COMPOSITION OF VIRUS POPULATIONS IN THE COURSE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 173(2), 1996, pp. 349-354
IMMUNOLOGICAL AND VIROLOGICAL MARKERS DETERMINING PROGRESSION TO AIDS(REPRINTED FROM NETH J MED, VOL 45, PG 288-293, 1994)
Authors: SCHELLEKENS PTA KOOT M ROOS MTL TERSMETTE M MIEDEMA F
Citation: Pta. Schellekens et al., IMMUNOLOGICAL AND VIROLOGICAL MARKERS DETERMINING PROGRESSION TO AIDS(REPRINTED FROM NETH J MED, VOL 45, PG 288-293, 1994), Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 62-66
TEMPORAL RELATIONSHIP BETWEEN ELONGATION OF THE HIV TYPE-1 GLYCOPROTEIN-120 V2 DOMAIN AND THE CONVERSION TOWARD A SYNCYTIUM-INDUCING PHENOTYPE
Authors: FOUCHIER RAM BROERSEN SM BROUWER M TERSMETTE M VANTWOUT AB GROENINK M SCHUITEMAKER H
Citation: Ram. Fouchier et al., TEMPORAL RELATIONSHIP BETWEEN ELONGATION OF THE HIV TYPE-1 GLYCOPROTEIN-120 V2 DOMAIN AND THE CONVERSION TOWARD A SYNCYTIUM-INDUCING PHENOTYPE, AIDS research and human retroviruses, 11(12), 1995, pp. 1473-1478
VIRAL LOAD AND SURROGATE MARKERS IN A PROSPECTIVE-STUDY OF ASYMPTOMATIC HIV-1-INFECTED PERSONS
Authors: BRUISTEN S FRISSEN J HUISMAN J WEIGEL H VANSWIETEN P DEVRIES E REGEZ R HARRIGAN R TERSMETTE M REISS P
Citation: S. Bruisten et al., VIRAL LOAD AND SURROGATE MARKERS IN A PROSPECTIVE-STUDY OF ASYMPTOMATIC HIV-1-INFECTED PERSONS, Journal of cellular biochemistry, 1995, pp. 202-202
ENVELOPE V2 CONFIGURATION AND HIV-1 PHENOTYPE - CLARIFICATION
Authors: SCHUITEMAKER H FOUCHIER RAM BROERSEN S GROENINK M KOOT M VANTWOUT AB HUISMAN HG TERSMETTE M MIEDEMA F
Citation: H. Schuitemaker et al., ENVELOPE V2 CONFIGURATION AND HIV-1 PHENOTYPE - CLARIFICATION, Science, 268(5207), 1995, pp. 115-115
T-CELL FUNCTION IN-VITRO IS AN INDEPENDENT PROGRESSION MARKER FOR AIDS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ASYMPTOMATIC SUBJECTS
Authors: ROOS MTL MIEDEMA F KNOT M TERSMETTE M SCHAASBERG WP COUTINHO RA SCHELLEKENS PTA
Citation: Mtl. Roos et al., T-CELL FUNCTION IN-VITRO IS AN INDEPENDENT PROGRESSION MARKER FOR AIDS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ASYMPTOMATIC SUBJECTS, The Journal of infectious diseases, 171(3), 1995, pp. 531-536
DEVELOPMENT AND EVALUATION OF AN HIV-1 TRANSFECTION-NEUTRALIZATION ASSAY
Authors: BACK NKT SMIT L HOGERVORST E VANWIJK ACWA GOUDSMIT J TERSMETTE M
Citation: Nkt. Back et al., DEVELOPMENT AND EVALUATION OF AN HIV-1 TRANSFECTION-NEUTRALIZATION ASSAY, Journal of acquired immune deficiency syndromes, 7(6), 1994, pp. 531-538
IMMUNOLOGICAL AND VIROLOGICAL MARKERS DETERMINING PROGRESSION TO AIDS
Authors: SCHELLEKENS PTA KOOT M ROOS MTL TERSMETTE M MIEDEMA F
Citation: Pta. Schellekens et al., IMMUNOLOGICAL AND VIROLOGICAL MARKERS DETERMINING PROGRESSION TO AIDS, Netherlands journal of medicine, 45(6), 1994, pp. 238-243
CHANGING VIRUS-HOST INTERACTIONS IN THE COURSE OF HIV-1 INFECTION
Authors: MIEDEMA F MEYAARD L KOOT M KLEIN MR ROOS MTL GROENINK M FOUCHIER RAM VANTWOUT AB TERSMETTE M SCHELLEKENS PTA SCHUITEMAKER H
Citation: F. Miedema et al., CHANGING VIRUS-HOST INTERACTIONS IN THE COURSE OF HIV-1 INFECTION, Immunological reviews, 140, 1994, pp. 35-72
AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION
Authors: BACK NKT SMIT L DEJONG JJ KEULEN W SCHUTTEN M GOUDSMIT J TERSMETTE M
Citation: Nkt. Back et al., AN N-GLYCAN WITHIN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 V3 LOOP AFFECTS VIRUS NEUTRALIZATION, Virology, 199(2), 1994, pp. 431-438
IDENTIFICATION OF INDIVIDUAL AMINO-ACIDS WITHIN THE V3 REGION DETERMINING SYNCYTIUM FORMATION AND REPLICATION RATE OF VIRUSES CHIMERIC FOR V3
Authors: DEJONG J DERONDE A KEULEN W TERSMETTE M GOUDSMIT J
Citation: J. Dejong et al., IDENTIFICATION OF INDIVIDUAL AMINO-ACIDS WITHIN THE V3 REGION DETERMINING SYNCYTIUM FORMATION AND REPLICATION RATE OF VIRUSES CHIMERIC FOR V3, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 686-686
EARLY REPLICATION STEPS BUT NOT CELL-TYPE-SPECIFIC SIGNALING OF THE VIRAL LONG TERMINAL REPEAT DETERMINE HIV-1 MONOCYTOTROPISM
Authors: SCHUITEMAKER H GROENINK M MEYAARD L KOOTSTRA NA FOUCHIER RAM GRUTERS RA HUISMAN HG TERSMETTE M MIEDEMA F
Citation: H. Schuitemaker et al., EARLY REPLICATION STEPS BUT NOT CELL-TYPE-SPECIFIC SIGNALING OF THE VIRAL LONG TERMINAL REPEAT DETERMINE HIV-1 MONOCYTOTROPISM, AIDS research and human retroviruses, 9(7), 1993, pp. 669-675
GENETIC AIDS RISK-GROUP-DEPENDENT SEPARATION AND ANTIGENIC AIDS RISK-GROUP-INDEPENDENT DIVERSIFICATION OF HIV-1 VARIANTS DURING THE CURRENTAIDS EPIDEMIC
Authors: GOUDSMIT J HOGERVORST E ZWART G TERSMETTE M DEJONG JJ KUIKEN C
Citation: J. Goudsmit et al., GENETIC AIDS RISK-GROUP-DEPENDENT SEPARATION AND ANTIGENIC AIDS RISK-GROUP-INDEPENDENT DIVERSIFICATION OF HIV-1 VARIANTS DURING THE CURRENTAIDS EPIDEMIC, Journal of cellular biochemistry, 1993, pp. 9-9
MOLECULAR-BIOLOGY AND CLINICAL-SIGNIFICANCE OF HIV-1 BIOLOGICAL PHENOTYPE
Authors: SCHUITEMAKER H TERSMETTE M KOOT M GROENINK M FOUCHIER RAM MEYAARD L HUISMAN H MIEDEMA F
Citation: H. Schuitemaker et al., MOLECULAR-BIOLOGY AND CLINICAL-SIGNIFICANCE OF HIV-1 BIOLOGICAL PHENOTYPE, Journal of cellular biochemistry, 1993, pp. 10-10
PHENOTYPE-RELATED DIFFERENCES IN EFFICACY OF ZIDOVUDINE TREATMENT OF ASYMPTOMATIC HIV-1 INFECTED INDIVIDUALS
Authors: TERSMETTE M KOOT M BOUCHER CAB MULDER JW LANGE JMA COUTINHO RA MIEDEMA F
Citation: M. Tersmette et al., PHENOTYPE-RELATED DIFFERENCES IN EFFICACY OF ZIDOVUDINE TREATMENT OF ASYMPTOMATIC HIV-1 INFECTED INDIVIDUALS, Journal of cellular biochemistry, 1993, pp. 24-24
AN N-GLYCAN WITHIN THE HIV-1 GP120 V3 LOOP IS INVOLVED IN THE MASKINGOF V3-BINDING AND CD4-BINDING NEUTRALIZATION SITES
Authors: BACK NKT SMIT L SCHUTTEN M DEJONG JJ KEULEN W GOUDSMIT J TERSMETTE M
Citation: Nkt. Back et al., AN N-GLYCAN WITHIN THE HIV-1 GP120 V3 LOOP IS INVOLVED IN THE MASKINGOF V3-BINDING AND CD4-BINDING NEUTRALIZATION SITES, Journal of cellular biochemistry, 1993, pp. 25-25
ROLE OF THE HIV-1 GP120 DOMAINS V1, V2, AND V3 IN DETERMINING CYTOPATHOGENICITY
Authors: GROENINK M FOUCHIER RAM BROERSEN S BAKER CH VANDERJAGT RCM MIEDEMA F HUISMAN HG TERSMETTE M SCHUITEMAKER H
Citation: M. Groenink et al., ROLE OF THE HIV-1 GP120 DOMAINS V1, V2, AND V3 IN DETERMINING CYTOPATHOGENICITY, Journal of cellular biochemistry, 1993, pp. 29-29
VIRULENT HIV STRAINS
Authors: TERSMETTE M SCHUITEMAKER H
Citation: M. Tersmette et H. Schuitemaker, VIRULENT HIV STRAINS, AIDS, 7(8), 1993, pp. 1123-1125
RELATION OF PHENOTYPE EVOLUTION OF HIV-1 TO ENVELOPE V2 CONFIGURATION
Authors: GROENINK M FOUCHIER RAM BROERSEN S BAKER CH KOOT M VANTWOUT AB HUISMAN HG MIEDEMA F TERSMETTE M SCHUITEMAKER H
Citation: M. Groenink et al., RELATION OF PHENOTYPE EVOLUTION OF HIV-1 TO ENVELOPE V2 CONFIGURATION, Science, 260(5113), 1993, pp. 1513-1516
MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES
Authors: BACK NKT SMIT L SCHUTTEN M NARA PL TERSMETTE M GOUDSMIT J
Citation: Nkt. Back et al., MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES, Journal of virology, 67(11), 1993, pp. 6897-6902
LACK OF T-CELL DYSFUNCTION AND PROGRAMMED CELL-DEATH IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED CHIMPANZEES CORRELATES WITH ABSENCE OFMONOCYTOTROPIC VARIANTS
Authors: SCHUITEMAKER H MEYAARD L KOOTSTRA NA DUBBES R OTTO SA TERSMETTE M HEENEY JL MIEDEMA F
Citation: H. Schuitemaker et al., LACK OF T-CELL DYSFUNCTION AND PROGRAMMED CELL-DEATH IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED CHIMPANZEES CORRELATES WITH ABSENCE OFMONOCYTOTROPIC VARIANTS, The Journal of infectious diseases, 168(5), 1993, pp. 1140-1147
VIRAL PHENOTYPE AND T-CELL REACTIVITY IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1-INFECTED ASYMPTOMATIC MEN TREATED WITH ZIDOVUDINE
Authors: KOOT M SCHELLEKENS PTA MULDER JW LANGE JMA ROOS MTL COUTINHO RA TERSMETTE M MIEDEMA F
Citation: M. Koot et al., VIRAL PHENOTYPE AND T-CELL REACTIVITY IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1-INFECTED ASYMPTOMATIC MEN TREATED WITH ZIDOVUDINE, The Journal of infectious diseases, 168(3), 1993, pp. 733-736
PROGNOSTIC VALUE OF HIV-1 SYNCYTIUM-INDUCING PHENOTYPE FOR RATE OF CD4+ CELL DEPLETION AND PROGRESSION TO AIDS
Authors: KOOT M KEET IPM VOS AHV DEGOEDE REY ROOS MTL COUTINHO RA MIEDEMA F SCHELLEKENS PTA TERSMETTE M
Citation: M. Koot et al., PROGNOSTIC VALUE OF HIV-1 SYNCYTIUM-INDUCING PHENOTYPE FOR RATE OF CD4+ CELL DEPLETION AND PROGRESSION TO AIDS, Annals of internal medicine, 118(9), 1993, pp. 681-688
Risultati: 1-24 |